Because commercial soursop bitters lack standardized regulation, the margin between an uncomfortable digestive episode and an emergency room admission is remarkably narrow. Clear contraindications exist across several distinct patient populations:
- Pregnant and Nursing Individuals: Graviola demonstrates marked uterotonic properties. The alkaloids stimulate uterine contractions, creating severe pregnancy contraindications including premature labor and miscarriage risk.
- Individuals on Antihypertensive Therapies: Patients taking lisinopril, amlodipine, metoprolol, or related cardiac agents risk acute hypotensive shock when soursop compounds amplify their medication.
- Diabetic Patients on Glucose-Lowering Drugs: Combining bitters with insulin or oral sulfonylureas can trigger severe, unpredicted hypoglycemic episodes.
- Individuals with Preexisting Motor or Movement Disorders: Anyone with a familial history or clinical diagnosis of Parkinson's disease must eliminate soursop leaves, teas, and tonics entirely due to baseline annonacin susceptibility.
- Patients with Renal or Hepatic Impairment: Compromised filtration organs cannot safely clear the metabolic byproducts and alkaloids concentrated in commercial bitters.
